Translational Case Studies
Documented proofs-of-concept demonstrating how our proteomics platform correlates baseline cellular activation with therapeutic response.
Evidence for Patient-Stratification Workflows
Case studies show how Yatiri Bio connects proteomic baseline states, ex-vivo response data, and biomarker signatures for biopharma programs.
Clinical Proof
June 2026
Identifying a Venetoclax-Sensitive AML Subset with Matched Proteomics & Ex Vivo Models
How Yatiri Bio used unbiased mass-spectrometry profiling and baseline ProteoModels screening to isolate a highly sensitive patient responder signature for Venetoclax.
Indication: AML / Hematology
Read Case Study
In Progress
Q3 2026
Mapping Kinase Bypass Mechanisms in Homologous Recombination Deficient Ovarian Organoids
Analyzing active phosphoproteomics response profiles under PARP inhibition in HGSOC patient-derived ex-vivo models.
Indication: Ovarian / HGSOC
Coming Soon